Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute

[nonyabizznez]

Lilly expanding their cash for vials program does provide an off ramp for many that were paying for compound. It is only about $100-$200 more per month than compound if on a dose <=10mg.

Still super expensive compared to gray but for many this could be an option. With insurance my Zepbound co-pay is just over $200 (for any dose) so $500 without insurance isn't as crazy as it sounds, especially if you don't have access to, or don't want to go gray.

I think they released vials in the US in part to negate any compounding argument for odd dosages. Now if a patient says they can't tolerate 5mg and need 4mg it can happen. Takes the legs off one of the compounders main arguments. Some telehealth anticipated this from the beginning... I know Henry Meds initial dosage schedule didn't align with Lilly's and several telehealth offered unique dosages the moment Tirz came off the shortage list in the fall.

 

[AndyPanda]

Anyone else having trouble keeping their mouth shut? I am. I think it was Shakespeare who said something like “Discretion is the greater part of valor”

 

[raw_oyster_eater]

i don't know why a couple more weight loss drugs can't be expedited. so many in these damn trials that will take forever. maybe they can help with that.

 

[AndyPanda]

i don't know why a couple more weight loss drugs can't be expedited. so many in these damn trials that will take forever. maybe they can help with that.

I don’t know how something can be better than what’s already here. It seems so amazing to me as is. Unless it’s a competitor of NN or EL, there is no benefit to something else coming out. The smart financial play is to wait until the patent expires.

 

[raw_oyster_eater]

there's like 30 in development/testing. lets push some of them out.